100 related articles for article (PubMed ID: 31128619)
1. A data-driven approach for estimating the change-points and impact of major events on disease risk.
Carroll R; Lawson AB; Zhao S
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():111-118. PubMed ID: 31128619
[TBL] [Abstract][Full Text] [Related]
2. An analysis of hurricane impact across multiple cancers: Accessing spatio-temporal variation in cancer-specific survival with Hurricane Katrina and Louisiana SEER data.
Huse E; Malone J; Ruesch E; Sulak T; Carroll R
Health Place; 2020 May; 63():102326. PubMed ID: 32543419
[TBL] [Abstract][Full Text] [Related]
3. Bayesian accelerated failure time model for space-time dependency in a geographically augmented survival model.
Onicescu G; Lawson A; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Stat Methods Med Res; 2017 Oct; 26(5):2244-2256. PubMed ID: 26220537
[TBL] [Abstract][Full Text] [Related]
4. Temporally dependent accelerated failure time model for capturing the impact of events that alter survival in disease mapping.
Carroll R; Lawson AB; Zhao S
Biostatistics; 2019 Oct; 20(4):666-680. PubMed ID: 29939209
[TBL] [Abstract][Full Text] [Related]
5. Absolute risk models for subtypes of breast cancer.
Gail MH; Anderson WF; Garcia-Closas M; Sherman ME
J Natl Cancer Inst; 2007 Nov; 99(22):1657-9. PubMed ID: 18000214
[No Abstract] [Full Text] [Related]
6. Spatially-explicit survival modeling with discrete grouping of cancer predictors.
Onicescu G; Lawson AB; Zhang J; Gebregziabher M; Wallace K; Eberth JM
Spat Spatiotemporal Epidemiol; 2019 Jun; 29():139-148. PubMed ID: 31128623
[TBL] [Abstract][Full Text] [Related]
7. Gaining relevance from the random: Interpreting observed spatial heterogeneity.
Carroll R; Zhao S
Spat Spatiotemporal Epidemiol; 2018 Jun; 25():11-17. PubMed ID: 29751888
[TBL] [Abstract][Full Text] [Related]
8. Bayesian variable selection in the accelerated failure time model with an application to the surveillance, epidemiology, and end results breast cancer data.
Zhang Z; Sinha S; Maiti T; Shipp E
Stat Methods Med Res; 2018 Apr; 27(4):971-990. PubMed ID: 28034170
[TBL] [Abstract][Full Text] [Related]
9. The influence of marital status on the stage at diagnosis, treatment, and survival of older women with breast cancer.
Osborne C; Ostir GV; Du X; Peek MK; Goodwin JS
Breast Cancer Res Treat; 2005 Sep; 93(1):41-7. PubMed ID: 16184457
[TBL] [Abstract][Full Text] [Related]
10. Comparing breast cancer risk assessment models.
Gail MH; Mai PL
J Natl Cancer Inst; 2010 May; 102(10):665-8. PubMed ID: 20427429
[No Abstract] [Full Text] [Related]
11. Semiparametric Bayesian estimation of quantile function for breast cancer survival data with cured fraction.
Gupta C; Cobre J; Polpo A; Sinha D
Biom J; 2016 Sep; 58(5):1164-77. PubMed ID: 27162061
[TBL] [Abstract][Full Text] [Related]
12. A Molecular Subtype-Specific Stochastic Simulation Model of US Breast Cancer Incidence, Survival, and Mortality Trends from 1975 to 2010.
Munoz DF; Xu C; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):89S-98S. PubMed ID: 29554473
[TBL] [Abstract][Full Text] [Related]
13. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States.
Paciorek CJ; Liu Y;
Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153
[TBL] [Abstract][Full Text] [Related]
14. A correlated frailty model with long-term survivors for estimating the heritability of breast cancer.
Locatelli I; Rosina A; Lichtenstein P; Yashin AI
Stat Med; 2007 Sep; 26(20):3722-34. PubMed ID: 17139701
[TBL] [Abstract][Full Text] [Related]
15. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer presents at an earlier age in Mexican American women.
Boyle T; McPadden E
Breast J; 2004; 10(5):462-4. PubMed ID: 15327507
[No Abstract] [Full Text] [Related]
17. BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes.
Berry DA; Iversen ES; Gudbjartsson DF; Hiller EH; Garber JE; Peshkin BN; Lerman C; Watson P; Lynch HT; Hilsenbeck SG; Rubinstein WS; Hughes KS; Parmigiani G
J Clin Oncol; 2002 Jun; 20(11):2701-12. PubMed ID: 12039933
[TBL] [Abstract][Full Text] [Related]
18. Overestimation of hereditary breast cancer risk.
Iglehart JD; Miron A; Rimer BK; Winer EP; Berry D; Shildkraut MJ
Ann Surg; 1998 Sep; 228(3):375-84. PubMed ID: 9742920
[TBL] [Abstract][Full Text] [Related]
19. Estimating Breast Cancer Survival by Molecular Subtype in the Absence of Screening and Adjuvant Treatment.
Munoz DF; Plevritis SK
Med Decis Making; 2018 Apr; 38(1_suppl):32S-43S. PubMed ID: 29554464
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking and risk of breast cancer in women.
Russo IH
Lancet; 2002 Oct; 360(9339):1033-4. PubMed ID: 12383978
[No Abstract] [Full Text] [Related]
[Next] [New Search]
